Demystifying COVID-19 – COVID-19 China Timebomb How to prevent it? (26th Dec 2022)
Chairman’s interaction with CNBC-TV18 Halftime Report (23 Feb 2023)
Game Changer Under-Trial Drug WCK-5222 Shows Promise Against Hospital Superbugs CNN News 18 (22 Feb 2023)
View All
Chairman’s Profile
Being different and making a difference. That sums up the vision, philosophy, conviction and driving force behind Dr. Habil F Khorakiwala who revels in venturing down the road less travelled.
He founded Wockhardt in 1967. Today, the Wockhardt Group is India’s leading research-based, global healthcare enterprise with relevance in the fields of Pharmaceuticals, Biotechnology, Active Pharmaceutical Ingredients (APIs), and Super Speciality Hospitals.
Investor Information
Our investors, Wockhardt shareowners, are an important and valued constituent of the Wockhardt stakeholder universe.
While it is a matter of regulatory compliance, we also consider it as good governance and our duty and responsibility, to keep our investors informed and updated regularly about news, events and developments that impact our business and operations.
Investor Focus
FINANCIAL RESULTS FY23 Q3
FINANCIAL RESULTS FY23 Q2
FINANCIAL RESULTS FY23 Q1
About Us
Wockhardt is a leading, research-based, global enterprise with relevance in the fields of pharmaceuticals, biotechnology, and healthcare services.
Our multinational R&D and manufacturing facilities are spread across India, USA, UK and UAE, and our worldwide marketing presence includes over 30 countries across 6 continents.
Our Products
latest launches
legacy products
latest launches
-
Heparin Sodium Flushing Solution (previously known as Canusal
-
Heparin Sodium 5000 I.U./ml (previously known as Multiparin
-
Heparin Sodium Flushing Solution (previously known as Canusal
-
Heparin Sodium Flushing Solution (previously known as Canusal
-
Heparin Sodium Flushing Solution (previously known as Canusal
legacy products
-
Heparin Sodium Flushing Solution (previously known as Canusal
-
Heparin Sodium 5000 I.U./ml (previously known as Multiparin
-
Heparin Sodium Flushing Solution (previously known as Canusal
-
Heparin Sodium Flushing Solution (previously known as Canusal
-
Heparin Sodium Flushing Solution (previously known as Canusal
Media & Press
Team Wockhardt
Team Wockhardt exhibits a global work culture and mindset in complete alignment with organisational goals and strives to excel, collectively as well as individually. Whole-heartedly adopting the corporate credo of Life Wins, Team Wockhardt has in place a strong leadership team with the bandwidth to ably lead the organisation into the future.
View More
OUR DISCOVERY. ROAD TO RECOVERY.
Life threatened globally by rising multidrug-resistant
infections or Antimicrobial Resistance (AMR).
Zaynich® administered on compassionate ground and
saved over 50 lives. Now in Global phase III clinical trial.
Research Wins. Life Wins.
Our Motto
Global Reach
Our Business
Our Product Portfolio
India branded business
India Branded Business
API
Russia – CIS
UK
Irish Market
Emerging Markets
Quality Generics
INVESTOR FOCUS
FINANCIAL RESULTS FY26 Q1
FINANCIAL RESULTS FY25 Q4
FINANCIAL RESULTS FY25 Q3
Wockhardt: Q1 FY26 Highlights
Audited Financial Results (Standalone and Consolidated) for the quarter and the financial year ended 31st March 2025
9MFY25 EBITDA at Rs. 339 crore; growth by 89%
Media Coverage
Archives
-
Wockhardt Eyes ‘Healthy Bottom Line’ In Coming Quarters Amid US Tariff Concerns
12 August, 2025
-
How Wockhardt’s bet on multi-drug resistant infections is paying off
30 July, 2025
Voice of Wockhardians
My journey at Wockhardt began in April 2020, and it has been a transformative experience that has shaped my professional and personal growth.
LCS SRI VISHNU
AVP and Cluster Head, Sales & Marketing – Diabetes Business
At Wockhardt, I’ve found not only a fulfilling career but also a second family. The supportive and nurturing atmosphere cultivated by our Chairman has truly inspired me and my colleagues.
VIJAY MHATRE
Manager – Finance
Working at Wockhardt for over a decade, I’ve had a fulfilling experience, with diverse roles and projects that contributed to personal and professional growth.
JAGMOHAN SINGH RISHI
Head – Training, SFE & Digital Marketing, Sales Training
As the leader of the Drug Regulatory Affairs function for the Pharmaceuticals Business at our company, my primary responsibility is to guide the organization through the regulatory process to ensure successful translation of drug research and development into medicines for patients.
ZOHER SIHORWALA
Senior Vice President and Head – Drug Regulatory Affairs
My ten-year tenure with Wockhardt, a global pioneer in pharmaceuticals and biotechnology, has been a remarkable journey of growth and learning.
PRAVIN SAMBREY
Country Manager, International Marketing ROW
Every day, I am part of a zero ego team that’s pushing the boundaries of science to develop new antibiotics that can save lives.
DR. VINOD AHIRRAO
Senior Group Leader – Analytical Chemistry, Drug Discovery Research
Relocating from Delhi to Chhatrapati Sambhajinagar was initially challenging, but the welcoming environment and supportive colleagues made the transition seamless.
AISHWARIA V NAIR
Senior Research Associate – Project Management, Biotech R&D
One of the things I appreciate most about working at Wockhardt is the passion of every team member for top-quality scientific work. The team at Wockhardt is prodigious— every person is willing to help each other and celebrate successes together.
RAJESH CHAVAN
Senior Group Leader – Pharmacology, Drug Discovery Research
Every day, I am inspired by the privilege of working alongside a team of seasoned and unwaveringly dedicated scientists.
SNEHAL PALWE
Senior Research Scientist – Microbiology, Drug Discovery Research
The collaborative environment, continuous learning opportunities, and the chance to work on cutting-edge technology and digital atomization have truly enhanced my professional growth.
PRADEEP MISHRA
Manager – Information Technology
I find the work culture at Wockhardt warm and professional, people are very friendly and supportive. Everyone seems to be working to their highest standards, which creates a nice, effective and organized environment.
DR. MOHAMMAD USMAN SHAIKH
Group Leader – Chemistry, Drug Discovery Research
The most important aspect of Wockhardt is the exceptional leadership under whose guidance the scientific team’s efforts have led to remarkable achievements.
DR. ATUL KANSAGARA
Senior Group Leader – Toxicology, Drug Discovery Research
Wockhardt has allowed me to explore with freedom in the vast ocean of Biologics and Pharmaceuticals.
HARSHDA CHAKOLE
Junior Executive – Drug Regulatory Affairs
This empowering environment allows us to grow professionally while contributing to the higher purpose of our leadership ̶ to serve humanity through healthcare advancement and ultimately, to win lives.
DR. VIJAY CHAVAN
Senior Research Scientist – Medicinal Chemistry, Drug Discovery Research
Wockhardt has always encouraged learning, collaboration, and continuous
improvement. Being part of the IT team here has been both professionally fulfilling
and personally meaningful.
Anne Burrows
Senior Systems Analyst – IT Department, Wockhardt UK
Working at Wockhardt has allowed me to build on my leadership skills, grow
professionally, and be part of a team that values precision, safety, and teamwork.
It’s been a rewarding experience to contribute to a company that puts quality and
people first.
Graham Duckham
Team Leader – Despatch, Wockhardt UK
Beyond Pharmaceuticals
6 new drugs under development, accorded QIDP status by US FDA and in Phase III clinical stage, are being developed as novel antibiotics and are expected to significantly aid global efforts against Antimicrobial Resistance (AMR).
Wockhardt
Discovery
A chain of super-speciality hospitals offering world-class tertiary and quaternary healthcare services, Wockhardt Hospitals has built a reputation for quality, professionalism and positive outcomes.
Wockhardt
Hospitals
Associate Entity
Wockhardt Foundation implements several social initiatives to improve the quality of life of the underprivileged sections of society and manages to make a difference to over four million lives every year.
Wockhardt
Foundation
Associate Entity
Wockhardt Global School, Aurangabad, is a not-for-profit initiative dedicated to developing a student community of lifelong learners that imbibes skills, knowledge and values required for global citizenship.
Wockhardt
School
Associate Entity
A chain of super-speciality hospitals offering world-class tertiary and quaternary healthcare services, Wockhardt Hospitals has built a reputation for quality, professionalism and positive outcomes.
Wockhardt
Hospitals
Wockhardt Foundation implements several social initiatives to improve the quality of life of the underprivileged sections of society and manages to make a difference to over four million lives every year.
Wockhardt
Foundation
Wockhardt Global School, Aurangabad, is a not-for-profit initiative dedicated to developing a student community of lifelong learners that imbibes skills, knowledge and values required for global citizenship.
Hi, this is a comment.
To get started with moderating, editing, and deleting comments, please visit the Comments screen in the dashboard.
Commenter avatars come from Gravatar.